Search Results - "KALENDER, MEHMET EMIN"

Collision tumor consisting of primary follicular lymphoma and adenocarcinoma in the cecum: A case report and literature review by KUS, TULAY, AKTAS, GOKMEN, KALENDER, MEHMET EMIN, SARI, IBRAHIM, ULKER, ESRA, CAMCI, CELALETDIN

“…The present study reports the case of a collision tumor consisting of follicular lymphoma (FL) and adenocarcinoma in the cecum of a 73-year-old man. To the…”
Get full text

High-throughput screening of Sirtuin family of genes in breast cancer by Igci, Mehri, Kalender, Mehmet Emin, Borazan, Ersin, Bozgeyik, Ibrahim, Bayraktar, Recep, Bozgeyik, Esra, Camci, Celaletdin, Arslan, Ahmet

“…Mammalian Sirtuins have been shown to perform distinct cellular functions and deregulated expression of these genes was reported to be involved in the…”
Get full text

Alpha-fetoprotein (AFP) Elevation Gastric Adenocarcinoma and Importance of AFP Change in Tumor Response Evaluation by Tatli, Ali Murat, Urakci, Zuhat, Kalender, Mehmet Emin, Arslan, Harun, Tastekin, Didem, Kaplan, Mehmet Ali

“…Background: Elevated serum alpha-fetoprotein (AFP) levels in adults are considered abnormal. This parameter is used mostly in the diagnosis and follow-up of…”
Get full text

Sorafenib with TACE improves the survival of hepatocellular carcinoma patients with more than 10 cm tumor: a single-center retrospective study by Aktas, Gokmen, Kus, Tulay, Emin Kalender, Mehmet, Kervancioglu, Selim, Sevinc, Alper, Kul, Seval, Camci, Celaletdin

“…Sorafenib, a multikinase inhibitor, is effective in patients with advanced hepatocellular carcinoma (HCC). Transarterial chemoembolization (TACE) is an…”
Get more information

Weekly Topotecan for Recurrent Small Cell Lung Cancer - a Retrospective Anatolian Medical Oncology Group Study by Altinbas, Mustafa, Kalender, Mehmet Emin, Oven, Basak, Sevinc, Alper, Karaca, Halit, Kaplan, M. Ali, Alici, Suleyman, Arpaci, Erkan, Yildiz, Ramazan, Uncu, Dogan, Camci, Celalettin, Gumus, Mahmut

“…Aim: To evaluate efficacy and tolerability of topotecan treatment for recurrent small cell lung carcinoma. Patients and Methods: A total of 62 patients were…”
Get full text

Weekly topotecan for recurrent small cell lung cancer - a retrospective Anatolian Medical Oncology Group study by Altinbas, Mustafa, Kalender, Mehmet Emin, Oven, Basak, Sevinc, Alper, Karaca, Halit, Kaplan, M Ali, Alici, Suleyman, Arpaci, Erkan, Yildiz, Ramazan, Uncu, Dogan, Camci, Celalettin, Gumus, Mahmut

“…To evaluate efficacy and tolerability of topotecan treatment for recurrent small cell lung carcinoma. A total of 62 patients were evaluated retrospectively…”
Get full text

Importance of HER2 Work-Up and Treatment Even in Patients with Poor Performance Status : A Case Report by Suner, Ali, Buyukhatipoglu, Hakan, Balakan, Ozan, Kalender, Mehmet Emin, Ulas, Turgay, Sevinc, Alper, Camci, Celalettin

“…Gastric cancer is one of most common types of cancers. Metastatic gastric cancer has a poor prognosis and is accepted as incurable at this stage. Treatment of…”
Get full text

Taxane-induced peripheral sensorial neuropathy in cancer patients is associated with duration of diabetes mellitus: a single-center retrospective study by Kus, Tulay, Aktas, Gokmen, Kalender, Mehmet Emin, Sevinc, Alper, Kul, Seval, Suner, Ali, Ulker, Esra, Camci, Celaletdin

“…Purpose The purpose of this study was to determine whether the presence of diabetes mellitus (DM) influences the incidence and severity of peripheral sensory…”
Get full text

Benign causes of increased serum CA-125 concentration by Sevinc, Alper, Adli, Mustafa, Kalender, Mehmet Emin, Camci, Celalettin

Get full text

Efficacy of venlafaxine for the relief of taxane and oxaliplatin-induced acute neurotoxicity: a single-center retrospective case–control study by Kus, Tulay, Aktas, Gokmen, Alpak, Gokay, Kalender, Mehmet Emin, Sevinc, Alper, Kul, Seval, Temizer, Mithat, Camci, Celaletdin

“…Background Oxaliplatin and taxane-induced neurosensory toxicity is dose-limiting and mostly presents with acute symptoms that affect the activities of daily…”
Get full text

Comparison of FOLFIRINOX Chemotherapy with Other Regimens in Patients with Biliary Tract Cancers: a Retrospective Study by Kus, Tulay, Aktas, Gokmen, Kalender, Mehmet Emin, Sevinc, Alper, Camci, Celaletdin

“…Purpose The aim of this retrospective study was to compare the different treatment options of patients with advanced biliary tract carcinoma (BTC) who were…”
Get full text

The relationship of miR-122-5p with trastuzumab therapy in breast cancer by Ergün, Sercan, Camci, Celaletdin, Temiz, Ebru, Ulasli, Mustafa, Kalender, Mehmet Emin, Sevinc, Alper, Oztuzcu, Serdar

“…Abstract only…”
Get full text

Polymorphism of CYP3A4 and ABCB1 genes increase the risk of neuropathy in breast cancer patients treated with paclitaxel and docetaxel by Kus, Tulay, Aktas, Gokmen, Kalender, Mehmet Emin, Demiryurek, Abdullah Tuncay, Ulasli, Mustafa, Oztuzcu, Serdar, Sevinc, Alper, Kul, Seval, Camci, Celaletdin

“…Interindividual variability of pharmacogenetics may account for unpredictable neurotoxicities of taxanes. From March 2011 to June 2015, female patients with…”
Get full text

The relationship between urotensin II and its receptor and the clinicopathological parameters of breast cancer by Balakan, Ozan, Kalender, Mehmet Emin, Suner, Ali, Cengiz, Beyhan, Oztuzcu, Serdar, Bayraktar, Recep, Borazan, Ersin, Babacan, Taner, Camci, Celaletdin

“…Urotensin II is a vasoactive polypeptide. It is known that some vasoactive polypeptides are produced and secreted by tumor cells, and act as a paracrine growth…”
Get full text

Alpha-fetoprotein (AFP) Elevation Gastric Adenocarcinoma and Importance of AFP Change in Tumor Response Evaluation by Tatli, Ali Murat, Urakci, Zuhat, Kalender, Mehmet Emin, Arslan, Harun, Tastekin, Didem, Kaplan, Mehmet Ali

Get full text

Could erlotinib treatment lead to acute cardiovascular events in patients with lung adenocarcinoma after chemotherapy failure? by Kus, Tulay, Aktas, Gokmen, Sevinc, Alper, Kalender, Mehmet Emin, Camci, Celaletdin

“…Erlotinib, an epidermal growth factor receptor and tyrosine kinase inhibitor, is a targeted drug that was approved for the treatment of non-small-cell lung…”
Get full text

Atypical presentation of disseminated intravascular coagulation with synchronous peripheral venous thromboembolism and arterial gangrene in a pancreatic cancer patient: a case report by Kus, Tulay, Kalender, Mehmet Emin, Aktas, Gokmen, Suner, Ali, Camci, Celaletdin

“…Cancer is a prothrombotic state and anticancer therapies are often complicated by vascular events. The risk of developing thromboembolic events is…”
Get full text

Prognostic impact of initial maximum standardized uptake value of 18F-FDG PET/CT on treatment response in patients with metastatic lung adenocarcinoma treated with erlotinib by Kus, Tulay, Aktas, Gokmen, Kalender, Mehmet Emin, Yilmaz, Mustafa, Kul, Seval, Oztuzcu, Serdar, Oktay, Cemil, Camci, Celaletdin, Sevinc, Alper

Get full text

TRP genes family expression in colorectal cancer and its relationship with prognostic factors by Kalender, Mehmet Emin, Sozucan, Yilmaz, Sari, Ibrahim, Suner, Ali, Oztuzcu, Serdar, Bozgeyik, Ibrahim, Cengiz, Beyhan, Igci, Yusuf Z, Balakan, Ozan, Camci, Celaletdin

“…Abstract only 513 Background: Different factors are effective in the development of colorectal cancer (CC). With the discovery of that TRP (transient receptor…”
Get full text

Survival analysis in second-line and third-line chemotherapy with irinotecan followed by topotecan or topotecan followed by irinotecan for extensive-stage small-cell lung cancer patients: a single-center retrospective study by Aktas, Gokmen, Kus, Tulay, Kalender, Mehmet Emin, Sevinc, Alper, Camci, Celaletdin, Kul, Seval

“…The number of patients who make it to receive third-line chemotherapy is increasing owing to the improvements in adverse-event management of chemotherapy for…”
Get full text